Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up

Improving recovery and quality of life after ostomy surgery for older adults

Official title: Improving Biopsychosocial Outcomes of Older Adults Undergoing Fecal Ostomy Surgery

Run by Massachusetts General Hospital · NCT07424586 · Data updated 2026-11-12

This pilot tests a web-based geriatric assessment program to help adults age 65+ recover and maintain quality of life after ileostomy or colostomy surgery.

More Ostomy - Ileostomy or Colostomy trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment16 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedFebruary 11, 2026
Main results expectedOctober 1, 2026
Study endsNovember 30, 2026
Registry record updatedJune 15, 2026
Trial IDNCT07424586 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults age 65 or older who are scheduled for a fecal ostomy (ileostomy or colostomy), can complete consent and web-based interactions, and are receiving care at the study site, along with their clinicians.

Probably not a fit

Patients with cognitive impairment that prevents completion of consent via the teach-back method or those not treated at the study site are unlikely to be eligible or to benefit from this pilot.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early-phase interventional pilot is testing the Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA) for acceptability and usability in older adults undergoing fecal ostomy surgery. Participants are patients age 65 and older who are having ileostomy or colostomy surgery, together with their clinicians, and the intervention is delivered via a web-based platform with perioperative follow-up in the days after surgery. The study will collect usability and acceptability data along with biopsychosocial and patient-centered recovery outcomes to inform refinements. The work is being conducted at Massachusetts General Hospital and is intended to determine whether the intervention is easy to use and feasible before larger trials.

Why it matters

Potential benefit: If successful, the program could improve early recovery and quality of life after ostomy surgery by providing tailored biopsychosocial support to older patients.

How similar studies have gone: Web-based and geriatric assessment interventions have shown promise improving post-surgical and quality-of-life outcomes in older adults more broadly, but few prior studies have specifically targeted older patients receiving new fecal ostomies, so this application is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients Age 65+ years
* clinicians age 18+ years
* Patients undergoing fecal ostomy surgery and their clinicians

Exclusion Criteria:

* cognitive impairment not allowing completion of consent procedures based on the teach-back method.

Where it's running

  • MassGeneral Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Christy Cauley, MD, MPH — MassGeneral Hospital
  • Study coordinator: Christy Cauley, MD, MPH
  • Email: ccauley@mgb.org
  • Phone: 617-726-8129

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.